Cargando…
Role of Genetic Ancestry in 1,002 Brazilian Colorectal Cancer Patients From Barretos Cancer Hospital
Background: Colorectal cancer (CRC) is the third most frequent and the second deadliest cancer worldwide. The ethnic structure of the population has been gaining prominence as a cancer player. The purpose of this study was to determine the genetic ancestry of Brazilian CRC patients. Moreover, we int...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065467/ https://www.ncbi.nlm.nih.gov/pubmed/32195168 http://dx.doi.org/10.3389/fonc.2020.00145 |
_version_ | 1783505071238021120 |
---|---|
author | Durães, Ronilson Oliveira Berardinelli, Gustavo Noriz da Costa, Allini Mafra Scapulatempo-Neto, Cristovam Pereira, Rui Oliveira, Marco Antônio Guimarães, Denise Peixoto Reis, Rui Manuel |
author_facet | Durães, Ronilson Oliveira Berardinelli, Gustavo Noriz da Costa, Allini Mafra Scapulatempo-Neto, Cristovam Pereira, Rui Oliveira, Marco Antônio Guimarães, Denise Peixoto Reis, Rui Manuel |
author_sort | Durães, Ronilson Oliveira |
collection | PubMed |
description | Background: Colorectal cancer (CRC) is the third most frequent and the second deadliest cancer worldwide. The ethnic structure of the population has been gaining prominence as a cancer player. The purpose of this study was to determine the genetic ancestry of Brazilian CRC patients. Moreover, we intended to interrogate its impact on patients' clinicopathological features. Methods: Retrospective observational cohort study with 1,002 patients with CRC admitted from 2000 to 2014 at Barretos Cancer Hospital. Following tumor DNA isolation, genetic ancestry was assessed using a specific panel of 46 ancestry informative markers. Survival rates were obtained by the Kaplan–Meier method, and the log-rank test was used to compare the survival curves. Multivariable Cox proportional regression models were used to estimate hazard ratios (HRs). Results: We observed considerable admixture in the genetic composition, with the following average proportions: European 74.2%, African 12.7%, Asian 6.5%, and Amerindian 6.6%. The multivariate analysis for cancer-specific survival showed that clinical stage, lymphovascular invasion, and the presence of recurrence were associated with an increased relative risk of death from cancer (p < 0.05). High African proportion was associated with younger age at diagnosis, while high Amerindian proportion was associated with the mucinous histological subtype. Conclusions: This represents the larger assessment of genetic ancestry in a population of Brazilian patients with CRC. Brazilian CRC patients exhibited similar clinicopathological features as described in Western countries. Impact: Genetic ancestry components corroborated the significant admixture, and importantly, patients with high African proportion develop cancer at a younger age. |
format | Online Article Text |
id | pubmed-7065467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70654672020-03-19 Role of Genetic Ancestry in 1,002 Brazilian Colorectal Cancer Patients From Barretos Cancer Hospital Durães, Ronilson Oliveira Berardinelli, Gustavo Noriz da Costa, Allini Mafra Scapulatempo-Neto, Cristovam Pereira, Rui Oliveira, Marco Antônio Guimarães, Denise Peixoto Reis, Rui Manuel Front Oncol Oncology Background: Colorectal cancer (CRC) is the third most frequent and the second deadliest cancer worldwide. The ethnic structure of the population has been gaining prominence as a cancer player. The purpose of this study was to determine the genetic ancestry of Brazilian CRC patients. Moreover, we intended to interrogate its impact on patients' clinicopathological features. Methods: Retrospective observational cohort study with 1,002 patients with CRC admitted from 2000 to 2014 at Barretos Cancer Hospital. Following tumor DNA isolation, genetic ancestry was assessed using a specific panel of 46 ancestry informative markers. Survival rates were obtained by the Kaplan–Meier method, and the log-rank test was used to compare the survival curves. Multivariable Cox proportional regression models were used to estimate hazard ratios (HRs). Results: We observed considerable admixture in the genetic composition, with the following average proportions: European 74.2%, African 12.7%, Asian 6.5%, and Amerindian 6.6%. The multivariate analysis for cancer-specific survival showed that clinical stage, lymphovascular invasion, and the presence of recurrence were associated with an increased relative risk of death from cancer (p < 0.05). High African proportion was associated with younger age at diagnosis, while high Amerindian proportion was associated with the mucinous histological subtype. Conclusions: This represents the larger assessment of genetic ancestry in a population of Brazilian patients with CRC. Brazilian CRC patients exhibited similar clinicopathological features as described in Western countries. Impact: Genetic ancestry components corroborated the significant admixture, and importantly, patients with high African proportion develop cancer at a younger age. Frontiers Media S.A. 2020-03-04 /pmc/articles/PMC7065467/ /pubmed/32195168 http://dx.doi.org/10.3389/fonc.2020.00145 Text en Copyright © 2020 Durães, Berardinelli, da Costa, Scapulatempo-Neto, Pereira, Oliveira, Guimarães and Reis. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Durães, Ronilson Oliveira Berardinelli, Gustavo Noriz da Costa, Allini Mafra Scapulatempo-Neto, Cristovam Pereira, Rui Oliveira, Marco Antônio Guimarães, Denise Peixoto Reis, Rui Manuel Role of Genetic Ancestry in 1,002 Brazilian Colorectal Cancer Patients From Barretos Cancer Hospital |
title | Role of Genetic Ancestry in 1,002 Brazilian Colorectal Cancer Patients From Barretos Cancer Hospital |
title_full | Role of Genetic Ancestry in 1,002 Brazilian Colorectal Cancer Patients From Barretos Cancer Hospital |
title_fullStr | Role of Genetic Ancestry in 1,002 Brazilian Colorectal Cancer Patients From Barretos Cancer Hospital |
title_full_unstemmed | Role of Genetic Ancestry in 1,002 Brazilian Colorectal Cancer Patients From Barretos Cancer Hospital |
title_short | Role of Genetic Ancestry in 1,002 Brazilian Colorectal Cancer Patients From Barretos Cancer Hospital |
title_sort | role of genetic ancestry in 1,002 brazilian colorectal cancer patients from barretos cancer hospital |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065467/ https://www.ncbi.nlm.nih.gov/pubmed/32195168 http://dx.doi.org/10.3389/fonc.2020.00145 |
work_keys_str_mv | AT duraesronilsonoliveira roleofgeneticancestryin1002braziliancolorectalcancerpatientsfrombarretoscancerhospital AT berardinelligustavonoriz roleofgeneticancestryin1002braziliancolorectalcancerpatientsfrombarretoscancerhospital AT dacostaallinimafra roleofgeneticancestryin1002braziliancolorectalcancerpatientsfrombarretoscancerhospital AT scapulatemponetocristovam roleofgeneticancestryin1002braziliancolorectalcancerpatientsfrombarretoscancerhospital AT pereirarui roleofgeneticancestryin1002braziliancolorectalcancerpatientsfrombarretoscancerhospital AT oliveiramarcoantonio roleofgeneticancestryin1002braziliancolorectalcancerpatientsfrombarretoscancerhospital AT guimaraesdenisepeixoto roleofgeneticancestryin1002braziliancolorectalcancerpatientsfrombarretoscancerhospital AT reisruimanuel roleofgeneticancestryin1002braziliancolorectalcancerpatientsfrombarretoscancerhospital |